← Back to Search

Behavioural Intervention

Financial Incentives for Smoking Cessation

N/A
Recruiting
Led By Michelle R vanDellen, PhD
Research Sponsored by University of Georgia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study the effectiveness of financial incentives for smoking cessation in dual-smoker couples (DSCs). DSCs are less likely to try to quit smoking and more likely to relapse

Who is the study for?
This trial is for couples where both partners smoke cigarettes. They must be willing to try quitting together and participate in a study that involves financial incentives as motivation. Specific eligibility details are not provided, but typically participants would need to meet certain health criteria and commit to the study's schedule.
What is being tested?
The trial tests two versions of Financial Incentive Treatments (FITs) designed to help dual-smoker couples quit smoking. Participants will receive usual care plus potential cash rewards for abstaining from smoking at set intervals. One group gets incentives just for one partner, while the other group has both partners receiving incentives.
What are the potential side effects?
Since this trial involves financial incentives rather than medical treatments or drugs, there aren't traditional side effects like you'd expect with medication. However, stress or tension could arise from trying to quit smoking, especially under a structured program.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Point-Prevalence Abstinence at End of Treatment
Secondary study objectives
Partner Point-Prevalence Abstinence
Point-Prevalence Abstinence After Treatment
Point-Prevalence Abstinence at First Follow-up
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Single-Target FIT (SFIT)Experimental Treatment1 Intervention
One couple member offered incentives. Targets in the SFIT condition will be offered financial incentives for biochemically verified abstinence ($200 at each of three follow-ups \[1, 3, and 6 Month\]).
Group II: Dyadic-FIT condition (DFIT)Experimental Treatment1 Intervention
Both couple members offered incentives and tracked across 12 months. Both targets and partners will be offered financial incentives for abstinence. Thus, in this condition, the total financial incentives offered to the dyad are twice the amount as offered to participants in the SFIT condition.
Group III: No-FIT Treatment-as-Usual (TAU) ConditionActive Control1 Intervention
Participants in the no-FIT control condition will not receive incentives.

Find a Location

Who is running the clinical trial?

University of GeorgiaLead Sponsor
103 Previous Clinical Trials
44,158 Total Patients Enrolled
McMaster UniversityOTHER
916 Previous Clinical Trials
2,614,328 Total Patients Enrolled
University of KentuckyOTHER
192 Previous Clinical Trials
222,722 Total Patients Enrolled
~600 spots leftby May 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top